Zarontin | Ethosuximide Capsule Breastfeeding

For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Zarontin | Ethosuximide Capsule and its risk associated with lactation. We will also discuss the usage of Zarontin | Ethosuximide Capsule and some common side effects associated with Zarontin | Ethosuximide Capsule.

What is Zarontin | Ethosuximide Capsule used for?


Zarontin is indicated for the control of absence (petit mal) epilepsy.

Zarontin | Ethosuximide Capsule while breastfeeding safe or not? Can there be any side effects for infant while using it during breastfeeding?

Zarontin | Ethosuximide Capsule high risk while breastfeeding
As Zarontin | Ethosuximide Capsule is made of only Ethosuximide, and Ethosuximide is unsafe to use in breastfeeding we can safely reach on conclusion that Zarontin | Ethosuximide Capsule is also unsafe to use while breastfeeding. Below is detailed analysis of Ethosuximide and Zarontin | Ethosuximide Capsule during location. We recommend you to go through provided detailed analysis as below take decision accordingly. We also recommend you talk to your health care provider before making final decision.

Zarontin | Ethosuximide Capsule Breastfeeding Analsys


Ethosuximide while Breastfeeding

Unsafe

CAS Number: 77-67-8

Some cases of sedation and hyperexcitability and weak suction have been described. It have been reported, though, one case of two months lasting irritability and insomnia in an infant born to a mother who had taken the drug during pregnancy but did not breastfeed the child. If a pregnant woman has not been switched to other anti-convulsivant drug it would be a better option for the mother to keep-on suckling her child and follow-up the infant closely.

Zarontin | Ethosuximide Capsule Breastfeeding Analsys - 2


Ethosuximide while Breastfeeding

CAS Number: 77-67-8

Average ethosuximide dosages of 50 to 60% of the maternal weight-adjusted dosage are excreted in human milk and infant plasma levels of 25 to 30% of maternal levels are common. Although no adverse effects attributable solely to ethosuximide in breastmilk have been reported, monitor the infant for drowsiness, adequate weight gain, and developmental milestones, especially in younger, exclusively breastfed infants and when using combinations of anticonvulsants. Measurement of an infant serum level might help rule out toxicity if there is a concern.


What should I do if I am breastfeeding mother and I am already exposed to Zarontin | Ethosuximide Capsule?

If you observer abnormal behavior or any other health issue in infant then you should immediately call 911 or contact other contact other emergency service provider in your area otherwise closely monitor the baby and inform your doctor about your Zarontin | Ethosuximide Capsule usage and time interval of breastfeeding.


I am nursing mother and my doctor has suggested me to use Zarontin | Ethosuximide Capsule, is it safe?

If your doctor knows that you are breastfeeding mother and still prescribes Zarontin | Ethosuximide Capsule then there must be good reason for that as Zarontin | Ethosuximide Capsule is considered unsafe, It usually happens when doctor finds that overall advantage of taking outweighs the overall risk.


If I am using Zarontin | Ethosuximide Capsule, will my baby need extra monitoring?

Yes, Extra monitoring is required if mother is using Zarontin | Ethosuximide Capsule and breastfeeding as it is considered unsafe for baby.


Who can I talk to if I have questions about usage of Zarontin | Ethosuximide Capsule in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week

Drug Brands with same Active ingredients

Ethosuximide Capsule
Ethosuximide Solution
Zarontin | Ethosuximide Solution
Zarontin | Ethosuximide Capsule